Studies parameters

Sustainable remission

p value

Gender

Female (n = 796)

321 (40.3%)

0.049

Male (n = 244)

83 (34%)

Age

[0 - 25 years] (n = 404)

146 (36.1%)

0.006

[26 - 50 years] (n = 535)

207 (38.7%)

Over 50 years (n = 101)

51 (50.5%)

Orbitopathy

Yes (n = 735)

270 (36.7%)

0.011

No (n = 305)

134 (43.9%)

Size of goiter

Grade 0 - 1 (n = 214)

108 (50.5%)

0.000

Grade 2 (n = 540)

210 (38.9%)

Grade 3 (n = 286)

86 (30.1%)

Initial dose of antithyroid

drugs (ATD)

≥40 mg/d (n = 648)

277 (42.7%)

0.183

<40 mg/d (n = 392)

157 (40.1%)

Delay to start the

maintenance treatment of ATD

≤3 months (n = 314)

148 (47.1%)

0.006

≥6 months (n = 726)

256 (35.3%)